Abbott Laboratories receives FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.
Abbott (NYSE:ABT) said it received FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1HAmspY
Cap comentari:
Publica un comentari a l'entrada